TrialCritical care (London, England)2011

Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes.

Adam M Deane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.